BCRX vs ZBRA · rev $874.8M vs P/E 28, rev $3.05B
BioCryst Pharmaceuticals Inc (BCRX) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported BCRX revenue for 2025-12-31 was $874.8M. Net income was $263.9M. BCRX currently screens at market cap $1.83B.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
BCRX currently screens at market cap $1.83B. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the BCRX and ZBRA stock pages for the full models.
Not investment advice.